ROIV
Roivant Sciences Ltd.
Key Financials
Net Income
$-171981000
↓ 104.0%
Revenue
$29.1M
↓ 76.7%
Operating Income
$-1003294000
↓ 123.7%
EPS (Diluted)
$-0.24
↓ 104.6%
Total Assets
$5.4B
↓ 24.7%
Shareholders' Equity
$4.7B
↓ 21.5%
Cash & Equivalents
$2.7B
↓ 58.5%
Total Liabilities
$249.7M
↓ 67.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ROIV |
| Company Name | Roivant Sciences Ltd. |
| CIK | 1635088 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | D0 |
| Phone | 441-295-5950 |